About Eric Keller
Eric Keller is a board member/president at Noveome Biotherapeutics.
Form D filings also name Eric Keller as a president and CEO at Response Pharmaceuticals and sits on its board.
Eric Keller first appears on SEC filings in 2022.
Experience
This experience comes from Eric Keller's profile and from SEC filings. For roles taken from filings, the years are when the filings name Eric Keller in the role, so the role may have started earlier or lasted longer.
RP
Retension Pharmaceuticals Current
CEO and Co-Founder
2023 – Present
Noveome Biotherapeutics, Inc. Current
Board Member/President
2022 – Present · Pittsburgh, PA
Develops experimental biologic treatments for infants with a serious intestinal disease and other patients.
SG
SGH2 Energy Global Current
Advisor
2021 – Present
Response Pharmaceuticals, Inc. Current
President and CEO, director
CEO and Co-Founder (2020 – Present)
2020 – Present · Falls Church, VA
RT
Redux Therapeutics Current
CEO and Co-Founder
2017 – Present
CI
C2Sense, Inc. Current
Co-Founder, Chief Strategy Officer
2014 – Present
SL
SipNose, Ltd.
Chief Business Officer
2015 – 2024
NI
nPute, Inc.
Co-Founder
2015 – 2018
NT
Nano-Terra
Chief Executive Officer, Co-Founder
2006 – 2014
AO
America Online
Senior Vice President, Business Affairs
1995 – 2001
Key Colleagues at Startups
The people Eric Keller works with at each company, as listed on that company's latest Form D.
Noveome Biotherapeutics, Inc. · Form D, Aug 27, 2026
Michael Kaufman
Director
HH
Houman Hemmati
Board Member
Ronald Poropatich
Board Member/Chairman of the Board
RL
Robert Langer
Director
Patrick Welch
CEO/Board Member
Larry Brown
Executive officer
Karin Potoka
Chief Medical Officer
Craig Nemiroff
Board Member
Response Pharmaceuticals, Inc. · Form D, Jun 28, 2024
MB
Michael Berendt
Director
DO
Donald Olds
Director